SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026009
Filing Date
2022-12-02
Accepted
2022-12-02 17:27:16
Documents
20
Period of Report
2022-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20221128.htm   iXBRL 8-K 68453
2 EX-10.1 sprb-ex10_1.htm EX-10.1 526107
3 EX-10.2 sprb-ex10_2.htm EX-10.2 1248237
4 GRAPHIC img106843575_0.jpg GRAPHIC 37390
5 GRAPHIC img106843575_1.jpg GRAPHIC 37390
6 GRAPHIC img106843575_2.jpg GRAPHIC 31066
7 GRAPHIC img106843575_3.jpg GRAPHIC 275511
8 GRAPHIC img107767096_0.jpg GRAPHIC 24809
9 GRAPHIC img107767096_1.jpg GRAPHIC 55686
  Complete submission text file 0000950170-22-026009.txt   2841306

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20221128.xsd EX-101.SCH 2501
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20221128_pre.xml EX-101.PRE 11520
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20221128_lab.xml EX-101.LAB 18527
14 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20221128_htm.xml XML 4899
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 221443107
SIC: 2834 Pharmaceutical Preparations